FinVolution (FINV) Q4 2025 Earnings Transcript

Full-year group revenue was RMB 13.6 billion (up 3.8% YoY) and net profit RMB 2.5 billion (up 6.6%), while full-year transaction volume fell to RMB 200 billion (−2.9%). Management guided 2026 group revenue to decline 5%–15% YoY amid China regulatory headwinds, but international business grew strongly (volume +38.6%, revenue +32%), is expected to be ~30% of 2026 revenue, and delivered >USD 15m combined operating profit in Indonesia and the Philippines; active international users doubled to 5.9 million. The company executed record shareholder returns (USD 107m buybacks in 2025, USD 40.7m in Q4; DPS USD 0.306, +10.5%), management purchased ~USD 1.9m of ADS, and completed the Fundo acquisition to enter the AUD 33 billion Australian unsecured loan market.

Analysis

Management has executed a deliberate shift from volume-driven China origination toward a higher-share international mix; that pivot creates a two-speed cash flow profile where near-term EPS is cushioned by capital returns while organic growth converts slower as overseas cohorts mature. The Australian acquisition is the inflection point: it buys regulatory clearance and a revenue base but also transfers execution risk to a market where funding, underwriting economics and customer acquisition dynamics are different — successful integration will lower group funding elasticity but only after several quarters of replatforming and capital allocation.

Early-warning credit metrics that recently peaked imply the China cycle may be closer to an inflection than a cliff, but tail risk remains asymmetric: a government-driven normalization of pricing or an unwinding of funding channels could compress margins rapidly. Conversely, the company’s playbook of embedding finance into high-frequency merchants in Southeast Asia compounds network effects — if product-market fit continues, lifetime values will lengthen and CAC efficiencies should widen, magnifying upside to ROIC over 12–36 months.

Buybacks plus insider purchases are a bullish signal on valuation but also constrain dry powder for opportunistic M&A or higher regulatory capital needs; expect management to continue using buybacks tactically to support the ADR while ramping international capex. The cleanest leading indicators to watch are (1) quarter-over-quarter change in international EBITDA margin, (2) speed of funding-cost convergence between Australia/SEA and China, and (3) first- and second-month vintage performance in newly originated international loans — each will re-rate the asset both ways within 3–12 months.

Key Decisions for Investors

• FINV — directional, offensive: Buy a 12–18 month call spread (long a ~0.45–0.55 delta call, short a 1.15–1.3x strike) sized to 2–3% of portfolio. Rationale: asymmetric upside if international profitability and buyback momentum continue; capped cost limits downside to premium paid. Timeframe: 6–18 months. Risk/Reward: limited downside (premium) vs 2–4x upside to breakeven if cross-border integration accelerates.
• FINV — defensive hedge: Purchase 9–12 month puts ~25–30% out-of-the-money (smaller notional, e.g., 0.5–1% portfolio) as protection against a China-driven regulatory shock or funding freeze. Rationale: protects capital during a rapid repricing event while retaining upside exposure elsewhere in the book. Timeframe: 3–12 months. Risk/Reward: premium cost vs protection against >20% drawdown scenarios.
• FINV — tactical income/vol play: If remaining buyback authorization is executed aggressively in the next quarter, initiate a covered-call or short-call-overwriting program on existing long exposure to monetize near-term upside while retaining core exposure. Rationale: converts buyback-driven support into immediate yield; suitable when volatility compresses post-buyback announcements. Timeframe: roll every 1–3 months. Risk/Reward: reduced upside beyond strike in exchange for collected premium that improves carry.